Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CD14 Stable Cell Line

    [CAT#: S01YF-1023-PY232]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    CD Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    CD
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;MGC-803
    Target Classification
    CD Cell Lines
    Target Research Area
    Orphan Receptor Research
    Related Diseases
    Mycobacterium Chelonae; Croup
    Gene ID
    Human:929
    UniProt ID
    Human:P08571

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    CD14 is a protein that plays a role in various biological processes and has applications in different fields of research. In the context of synovial fluid in arthritis, CD14 dim , OPG + , ZO-1 + cells consistent with resident synovial macrophages (RSM) were identified. These RSM are migratory and can initiate or coordinate both acute (septic) or chronic (autoimmune or inflammatory) arthritis. In neuromyelitis optica spectrum disorder (NMOSD), excessive expression of MALAT1, an upstream target of miR-30b-5p, leads to upregulation of BAFF expression. This promotes the immunologic process of NMOSD by stimulating B cell activation and proliferation. CD14+ monocytes in peripheral blood mononuclear cells (PBMCs) mediate the anti-inflammatory effects of n-3 PUFA-rich lipid emulsions in parenteral nutrition. These lipid emulsions increase the expression of CD1d and CD86 in CD14+ monocytes, leading to increased IL-10 production and reduced pro-inflammatory cytokines. In long-COVID, CD14+ monocytes and NKT cells show altered expression and interaction, contributing to long-term pulmonary dysfunction and metabolic syndrome. In metabolic dysfunction-associated fatty liver disease (MAFLD), CD14+ monocytes differentiate into monocyte-derived macrophages (MdMs) that accumulate in the liver. These MdMs participate in lipid uptake during early stages of MAFLD. Overall, CD14 has implications in immunoregulation, autoimmune disorders, nutrition, pulmonary function, and liver disease.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human CD14 Stable Cell Line (S01YF-1023-PY232). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Cameron Davis (Verified Customer)

    How does CD14 function in immune responses? Mar 05 2022

    chat Patrick Liam (Creative Biolabs Scientific Support)

    CD14 plays a critical role in immune responses, particularly in recognizing and binding lipopolysaccharides, and is involved in the pathogenesis of inflammation and various diseases. Mar 05 2022

    chat Alex Davis (Verified Customer)

    Can CD14 expression be influenced by external factors? Apr 26 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    External factors like honey bee venom and certain drugs can modulate CD14 expression, impacting monocyte differentiation and immune responses. Apr 26 2021

    Published Data

    Fig.1 Knockdown of CD14 in gastric cancer cell lines.

    A stable reduction in CD14 expression was achieved in gastric cancer MGC-803 cells, with detection conducted through RT-PCR and western blotting. Significantly lower levels (P<0.01) were observed when compared to cells transfected with negative control shRNA, and this was noted in three independent experiments. CD14, identified as cluster of differentiation 14, was the target of the knockdown.

    Ref: Li, Kang, et al. "CD14 regulates gastric cancer cell epithelial‑mesenchymal transition and invasion in vitro." Oncology reports 30.6 (2013): 2725-2732.

    Pubmed: 24064911

    DOI: 10.3892/or.2013.2733

    Research Highlights

    Sanhueza, Sergio. et al. "Clinical and pulmonary function analysis in long-COVID revealed that long-term pulmonary dysfunction is associated with vascular inflammation pathways and metabolic syndrome." Frontiers in medicine, 2023.
    Long-term pulmonary dysfunction (L-TPD), a crucial symptom of long-COVID, has been linked to disease severity and prior comorbidities during the acute phase. However, there is currently limited understanding of the specific clinical manifestations, associated consequences, and underlying molecular pathways of this condition. The objective of this research was to investigate and describe L-TPD in individuals with long-COVID, as well as identify the predominant pathways and long-term effects of this condition through comprehensive analysis of clinical parameters and functional assessments, aided by machine learning and serum proteome profiling.
    Sanhueza, Sergio. et al. "Clinical and pulmonary function analysis in long-COVID revealed that long-term pulmonary dysfunction is associated with vascular inflammation pathways and metabolic syndrome." Frontiers in medicine, 2023.
    Pubmed: 37869162   DOI: 10.3389/fmed.2023.1271863

    M Chan, Mandy. et al. "Steatosis drives monocyte-derived macrophage accumulation in human metabolic dysfunction-associated fatty liver disease." JHEP reports : innovation in hepatology, 2023.
    The study of metabolic dysfunction-associated fatty liver disease (MAFLD) has recently focused on the role of macrophage composition in hepatic steatosis, a common complication of obesity. Animal models have revealed significant changes in macrophage heterogeneity in MAFLD, but the connection between liver macrophages and steatosis remains inconclusive in human subjects. Thus, further research is needed to fully understand the relationship between liver macrophages and fatty liver disease in humans.
    M Chan, Mandy. et al. "Steatosis drives monocyte-derived macrophage accumulation in human metabolic dysfunction-associated fatty liver disease." JHEP reports : innovation in hepatology, 2023.
    Pubmed: 37869071   DOI: 10.1016/j.jhepr.2023.100877

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare